Navigation Links
Neurocrine Biosciences Reports Third Quarter 2008 Results
Date:10/28/2008

istrative expenses is primarily due to cost savings related to recent restructurings.

The Company's balance sheet on September 30, 2008 reflected total assets of $207.7 million, including cash and investments of $118.2 million compared with balances at December 31, 2007 of $276.7 million and $179.4 million, respectively. The Company expects to end 2008 with approximately $100 million in cash and investments.

"We are pleased with the progress of our GnRH program, especially the recent positive results of our 603 study where once a day elagolix showed profound efficacy with minimal impact on bone mineral density. We are also nearing completion of the final preclinical studies of urocortin 2 to allow for long-term Phase II clinical studies and our scientists have just recently identified a clinical candidate from our VMAT2 development program for movement disorders," said Kevin Gorman, Chief Executive Officer and President of Neurocrine Biosciences. "While we are making great strides in advancing our pipeline, we continue to prioritize expenditures and diligently manage our cash burn."

R & D Pipeline Update

Neurocrine's clinical development group and corporate partners have five programs in clinical development. Neurocrine scientists continue to supply Neurocrine's pipeline to meet the Company-wide goal of bringing one new compound into development each year.

Elagolix for Endometriosis

The Company recently announced the positive safety and efficacy results from the completed 6-month treatment phase of its Phase IIb clinical trial (PETAL Study) using its proprietary, orally-active nonpeptide Gonadotropin-Releasing Hormone (GnRH) receptor antagonist, elagolix.

The primary endpoint, percent change from baseline in mean bone mineral density (BMD) demonstrated elagolix did not induce significant bone loss over the six month treatment period. Additionally, elagolix also met the secondary endpoints of improvement in endometrios
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Webcast Alert: Neurocrine Announces 3Q 08 Financial Results
2. Neurocrine Biosciences to Present at the Oppenheimer 19th Annual Healthcare Conference
3. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2008 Financial Results
4. Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
5. Neurocrine Biosciences to Present at Thomas Weisel Healthcare Conference and the NewsMakers in the Biotech Industry Conference
6. Neurocrine Biosciences Reports Second Quarter 2008 Results
7. Neurocrine Biosciences Announces Conference Call and Webcast To Present Second Quarter 2008 Financial Results
8. Neurocrine Biosciences to Present at the 2008 Citi Investment Research Global Health Care Conference
9. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2008 Financial Results
10. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year End 2007 Financial Results
11. Neurocrine Announces Appointment of Kevin Gorman, Ph.D., as President and Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2014)... 2014 /PRNewswire/ - SQI Diagnostics Inc. (TSX-V: SQD), a life ... products for advanced microarray diagnostics, today announced it will ... at 2:00 pm ET.  During the ... brief review of SQI,s recent commercialization progress and then ... veteran recently appointed to the Board of Directors of ...
(Date:8/18/2014)... August 18, 2014 According ... Market Research "Life Science Reagents Market(Products- PCR Reagent ... Chromatography, In-Vitro Diagnostic Reagents and Others; End Users- ... Clinical Laboratories, and Forensic Laboratories)- Global Industry Analysis, ... 2019", the global life science reagents market was ...
(Date:8/18/2014)... 2014 Vier führende deutsche Augenzentren ... Studie auf, in der eine Intraokularlinse (IOL) ... Sehvermögen bei allen Entfernungen verbessern, so dass ... Lese- oder Gleitsichtbrille mehr benötigen. Die neue ... Accommodating Intraocular Lens (FluidVision akkomodative Intraokularlinse) ...
(Date:8/15/2014)... LAKE FOREST, Ill. , Aug. 15, 2014 /PRNewswire/ ... the world,s leading provider of injectable drugs and infusion ... the Morgan Stanley Global Healthcare Conference on Tuesday, Sept. ... The presentation is scheduled to begin at ...  It will be available to all interested parties through ...
Breaking Biology Technology:SQI Diagnostics Announces Investor Conference Call with Dr. Allan Pronovost 2SQI Diagnostics Announces Investor Conference Call with Dr. Allan Pronovost 3Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 2Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 3Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 4Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 5Implantation einer revolutionären akkommodativen Linse bei Katarakt-Patienten in deutschen Augenzentren im Rahmen einer internationalen klinischen Studie 2Implantation einer revolutionären akkommodativen Linse bei Katarakt-Patienten in deutschen Augenzentren im Rahmen einer internationalen klinischen Studie 3Implantation einer revolutionären akkommodativen Linse bei Katarakt-Patienten in deutschen Augenzentren im Rahmen einer internationalen klinischen Studie 4
... BioLife Solutions, Inc.,(OTC Bulletin Board: BLFS), a ... storage and cryopreservation media products for cells,tissues, ... Rutgers University Cell and DNA,Repository (RUCDR), ... the Company,s CryoStor as the exclusive cryopreservation ...
... Doubles Manufacturing Capacity; Expands Global Reach with Vietnam ... Alpine Biomed Corporation, a global leader in ... doubled its manufacturing capacity and expanded its worldwide ... The company will produce and distribute medical devices ...
... Conference Call Scheduled for 5:00 p.m. ETORANGE COUNTY, Calif., ... BEC ) announced today it will host a conference ... ET to discuss the company,s first quarter 2009 results. ... http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO )The call may be accessed by ...
Cached Biology Technology:Rutgers University Cell and DNA Repository Adopts BioLife Solutions CryoStor(TM) as Standard Biopreservation Media 2Rutgers University Cell and DNA Repository Adopts BioLife Solutions CryoStor(TM) as Standard Biopreservation Media 3Alpine Biomed Opens New Manufacturing Facility to Support Demand for Specialty Diagnostic Devices 2Alpine Biomed Opens New Manufacturing Facility to Support Demand for Specialty Diagnostic Devices 3Beckman Coulter Announces First Quarter 2009 Earnings to be Released on Tuesday, April 28, 2009, After Market Closes 2
(Date:8/19/2014)... Ill. A new study of 9- and 10-year-olds ... more fibrous and compact white-matter tracts in the brain ... describes the bundles of axons that carry nerve signals ... matter is associated with faster and more efficient nerve ... the open-access journal Frontiers in Human Neuroscience. , ...
(Date:8/18/2014)... 2014 ,Trustonic TEE ... smart devices  Trustonic, the leading provider ... and Fingerprint Cards AB (FPC) today announced a ... secure biometric authentication on connected devices. ... (FPC1020, FPC1021 and FPC1150) and sensor driver software ...
(Date:8/18/2014)... a new satellite image of Antarctica, and the imagery ... insight into the effects of climate change. , Thanks ... MacDonald, Dettwiler and Associates Ltd. (MDA), the prime contractor ... Network (CCIN) at UWaterloo, the mosaic is free and ... , Using Synthetic Aperture Radar with multiple polarization ...
Breaking Biology News(10 mins):Physically fit kids have beefier brain white matter than their less-fit peers 2Physically fit kids have beefier brain white matter than their less-fit peers 3Trustonic and Fingerprint Cards Collaborate to Bring Secure Biometrics to Connected Devices 2Trustonic and Fingerprint Cards Collaborate to Bring Secure Biometrics to Connected Devices 3Trustonic and Fingerprint Cards Collaborate to Bring Secure Biometrics to Connected Devices 4Waterloo makes public most complete Antarctic map for climate research 2
... edible dormice ( Glis glis ) are busy caring for ... to replenish their fat stores to cope with the upcoming ... pleasant taste and dormice have long been viewed as a ... fatten them up for eating, which explains the "edible" part ...
... pioneering online biology video sites, iBioSeminars and iBioMagazine, have ... with even more to offer the biology community. Following ... provide videos by world-class biologists for free. ... broad audience, says iBiology Director Sarah Goodwin PhD, including ...
... 2013 A study performed at Children,s Hospital Los Angeles ... children with optic nerve hypoplasia (ONH). Their results are reported ... Ophthalmology and Strabismus ( AAPOS ). ONH, an ... appear either as an isolated abnormality or as part of ...
Cached Biology News:Fat and fit 22 online science video pioneers combine to form new iBiology.org 2No evidence to support stem cell therapy for pediatric optic nerve hypoplasia 2No evidence to support stem cell therapy for pediatric optic nerve hypoplasia 3
... Physical Form: buffered aqueous solution. ... terminal galactose from complex carbohydrates and glycoproteins. ... galactose under conditions where the pH must ... live cells. Unit Definition: ...
... for human cardiac troponin subunit T, a 31kDa ... for contraction of cardiac muscle. It reacts with ... cells. It also cross-reacts with human skeletal troponin ... Highly purified human cardiac troponin T ...
cystatin A (N-18)...
... to offer the ATTO-TAG series of ... primary amines. Developed by Novotny and ... reagents are similar to the important ... anthracene-2,3-dicarboxaldehyde, all of which are also ...
Biology Products: